Podbregar Ana, Kocjan Tomaž, Rakuša Matej, Popović Peter, Garbajs Manca, Goricar Katja, Janez Andrej, Jensterle Mojca
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
University Rehabilitation Institute Republic of Slovenia, Ljubljana, Slovenia.
Endocr Connect. 2021 Jun 16;10(6):637-645. doi: 10.1530/EC-21-0196.
Most data on the natural history of nonfunctioning adrenal incidentalomas (NFAI) are provided by follow-ups up to 5 years. We conducted a 10.5 (9.1-11.9)-year prospective follow-up study of NFAI in 67 participants (20 (29.9%) males, 47 (70.1%) females) of mean age 57.9 (52.3-63.9) years and BMI 27.42 (24.07-30.56) kg/m2). We also evaluated the associations between baseline BMI and changes of NFAIs' characteristics at follow-up. Progression to mild autonomous cortisol excess (MACE) was observed in 15 (22 %) patients, with 14 of them having post overnight dexamethasone suppression test (ODST) cortisol between 50 and138 nmol/L and only one > 138 nmol/L. The progression rate was significantly higher in overweight and obese than in normal-weight subjects. Patients that developed MACE had a significantly higher baseline mean cortisol after 1 mg ODST. Tumor enlargement ≥10 mm occurred in 8.9% of patients. In comparison with reports of shorter observational periods, we observed a higher growth rate ≥ 10 mm and higher progression rate from NFAI to MACE, particularly in overweight and obese subjects. All tumors had persistent radiological characteristics typical for adrenal adenoma. We concluded that the duration of the follow-up period is an important factor in characterizing the natural history of NFAI. Higher baseline BMI and higher baseline cortisol after ODST might predict the long-term likelihood of progression in hormonal activity. The magnitudes of observed progressions in growth or hormonal activity were clinically insignificant. Our long-term follow-up, therefore, clearly supports the general view that a long-term monitoring of patients with NFAI is not necessary.
大多数关于无功能肾上腺偶发瘤(NFAI)自然病史的数据来自长达5年的随访研究。我们对67名参与者(20名(29.9%)男性,47名(70.1%)女性)进行了为期10.5(9.1 - 11.9)年的NFAI前瞻性随访研究,参与者的平均年龄为57.9(52.3 - 63.9)岁,体重指数(BMI)为27.42(24.07 - 30.56)kg/m²。我们还评估了基线BMI与随访时NFAI特征变化之间的关联。15名(22%)患者进展为轻度自主性皮质醇增多症(MACE),其中14名患者过夜地塞米松抑制试验(ODST)后皮质醇水平在50至138 nmol/L之间,只有1名患者>138 nmol/L。超重和肥胖患者的进展率显著高于正常体重受试者。发生MACE的患者在1 mg ODST后基线平均皮质醇水平显著更高。8.9%的患者出现肿瘤增大≥10 mm。与较短观察期的报告相比,我们观察到≥10 mm的生长率和从NFAI进展为MACE的发生率更高,尤其是在超重和肥胖受试者中。所有肿瘤均具有肾上腺腺瘤典型的持续放射学特征。我们得出结论,随访期的长短是描述NFAI自然病史的一个重要因素。较高的基线BMI和ODST后较高的基线皮质醇水平可能预示激素活性长期进展的可能性。观察到的生长或激素活性进展幅度在临床上无显著意义。因此,我们的长期随访明确支持了一般观点,即对NFAI患者进行长期监测没有必要。